SGH
JNJ icon

Sivik Global Healthcare’s Johnson & Johnson JNJ Stock Holding History

Sivik Global Healthcare’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.89M Hold
20,000
– – 3.71% 4
2026
Q1 		$4.89M Buy
+20,000
New +$4.66M 3.71% 4
2025
Q4 		– Sell
-25,000
Closed -$4.64M – 52
2025
Q3 		$4.64M Buy
+25,000
New +$4.28M 1.35% 29
2023
Q1 		– Sell
-15,000
Closed -$2.65M – 43
2022
Q4 		$2.65M Sell
15,000
-22,500
-60% -$3.88M 1.25% 35
2022
Q3 		$6.13M Buy
37,500
+12,500
+50% +$2.12M 3.4% 10
2022
Q2 		$4.44M Sell
25,000
-10,000
-29% -$1.78M 2.52% 18
2022
Q1 		$6.2M Buy
35,000
+5,000
+17% +$851K 2.56% 12
2021
Q4 		$5.13M Sell
30,000
-40,000
-57% -$6.55M 2.2% 24
2021
Q3 		$11.3M Buy
70,000
+15,000
+27% +$2.56M 2.7% 5
2021
Q2 		$9.06M Buy
55,000
+20,000
+57% +$3.31M 1.77% 13
2021
Q1 		$5.75M Sell
35,000
-30,000
-46% -$4.85M 2.1% 28
2020
Q4 		$10.2M Buy
65,000
+5,000
+8% +$738K 4.17% 1
2020
Q3 		$8.93M Buy
60,000
+30,000
+100% +$4.44M 3.84% 3
2020
Q2 		$4.22M Buy
+30,000
New +$4.37M 1.4% 32
2020
Q1 		– Sell
-35,000
Closed -$5.11M – 52
2019
Q4 		$5.11M Buy
+35,000
New +$4.75M 1.9% 31
2018
Q1 		– Sell
-30,000
Closed -$4.19M – 63
2017
Q4 		$4.19M Buy
+30,000
New +$4.18M 1.56% 29
2017
Q3 		– Sell
-70,000
Closed -$9.28M – 81
2017
Q2 		$9.26M Buy
+70,000
New +$8.93M 3.39% 3
2017
Q1 		– Sell
-35,000
Closed -$4.03M – 66
2016
Q4 		$4.03M Sell
35,000
-25,000
-42% -$2.89M 1.92% 23
2016
Q3 		$7.09M Buy
60,000
+20,000
+50% +$2.43M 3.57% 8
2016
Q2 		$4.85M Buy
+40,000
New +$4.55M 2.41% 12

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return

Sivik Global Healthcare's JNJ Position: Q2 2026 in Review

Sivik Global Healthcare held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 20,000 shares worth $4.89M. The position accounts for 3.71% of the portfolio, ranked #4.

Sivik Global Healthcare first reported a position in JNJ in Q2 2016 and has held it in 20 quarters since. The position peaked at $11.3M in Q3 2021. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Sivik Global Healthcare held 20,000 shares of Johnson & Johnson worth $4.89M as of Q2 2026.
  • Sivik Global Healthcare left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 3.71% of Sivik Global Healthcare's portfolio in Q2 2026, its #4 holding.
  • Sivik Global Healthcare first reported a position in Johnson & Johnson in Q2 2016 and has held it in 20 quarters since.
  • Sivik Global Healthcare's Johnson & Johnson position peaked at $11.3M in Q3 2021.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Sivik Global Healthcare's 13F filing for Q2 2026, filed 20 Jul 2026.